# Apple awards $10 million to COPAN Diagnostics to boost swab production

Apple awarded $10 million to COPAN Diagnostics to help expand into a larger facility and increase production of Covid-19 sample collection kits to 1 million per week by early July, creating 50 new jobs in Southern California.

- Type: Investment
- Announced: 2020-05-07
- Where: Murrieta, California, United States
- Value: $10.0M
- Jobs: 50
- Starts operating: Jul 2020
- Status: announced
- Capacity: 1 million collection kits per week
- Products: nasal swabs, sample collection kits, vials, sterile media
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [COPAN Diagnostics](https://endata.com/companies/47089.md)
- [Apple](https://endata.com/companies/2967.md) (investor)
- [K2 Kinetics](https://endata.com/companies/47090.md) (supplier)
- [MWES](https://endata.com/companies/47091.md) (supplier)

## Sources

- [investing.com](https://www.investing.com/news/stock-market-news/apple-awards-10-million-to-nasal-swab-maker-copan-diagnostics-to-help-boost-factory-output-2163999), 2020-05-07: "Apple's teams are already making a huge difference with our efforts to scale up the production of our sample collection and transport kits."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.
